Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Pharmacist Intervention Saves Hospital More Than $100,000 Over 1 Year
10/20/2022
Jolynn Tumolo
Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting pharmaceutical interventions for patient safety.
Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting pharmaceutical interventions for patient safety.
Tracing reports by pharmacists...
10/20/2022
Pharmacy Learning Network

Advertisement

News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
Jolynn Tumolo
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
News
Antifibrinolytic Injection Recalled
10/14/2022
Jolynn Tumolo
AuroMedics Pharma is voluntarily recalling a prescription antifibrinolytic due to the presence of a piece of metal in a vial.
AuroMedics Pharma is voluntarily recalling a prescription antifibrinolytic due to the presence of a piece of metal in a vial.
AuroMedics Pharma is voluntarily...
10/14/2022
Pharmacy Learning Network
News
Bronchodilator Recalled
10/14/2022
Jolynn Tumolo
A Class II recall has been issued for 103,150 vials of a prescription bronchodilator following the report of a hair found in a vial.
A Class II recall has been issued for 103,150 vials of a prescription bronchodilator following the report of a hair found in a vial.
A Class II recall has been...
10/14/2022
Pharmacy Learning Network

Advertisement

News
Class I, II Recalls for Hand Sanitizers Distributed in Two States
10/14/2022
Jolynn Tumolo
The US Food and Drug Administration has designated hand sanitizer recalls Class I and Class II due to contamination concerns.
The US Food and Drug Administration has designated hand sanitizer recalls Class I and Class II due to contamination concerns.
The US Food and Drug...
10/14/2022
Pharmacy Learning Network
News
Tuberculosis Drug Recalled
10/06/2022
Jolynn Tumolo
A Class II recall has been issued for 195,584 bottles of a prescription antibiotic used to treat tuberculosis.
A Class II recall has been issued for 195,584 bottles of a prescription antibiotic used to treat tuberculosis.
A Class II recall has been...
10/06/2022
Pharmacy Learning Network
News
Superpotent Capsules Recalled
10/06/2022
Jolynn Tumolo
Sun Pharmaceuticals Industries Inc is voluntarily recalling lots of a prescription proton pump inhibitor.
Sun Pharmaceuticals Industries Inc is voluntarily recalling lots of a prescription proton pump inhibitor.
Sun Pharmaceuticals Industries...
10/06/2022
Pharmacy Learning Network

Advertisement

News
Antibiotic Injection Recalled
10/06/2022
Jolynn Tumolo
A prescription antibiotic injection is under a Class II recall following the report of a strand of hair in a vial.
A prescription antibiotic injection is under a Class II recall following the report of a strand of hair in a vial.
A prescription antibiotic...
10/06/2022
Pharmacy Learning Network
News
Can Pharmacist Email Alerts Reduce Concurrent Prescribing of Opioids, Benzodiazepines?
10/05/2022
Samantha Matthews
Researchers explored whether concurrent prescribing could be reduced through pharmacist emails to practitioners caring for patients who recently received opioids and benzodiazepines.
Researchers explored whether concurrent prescribing could be reduced through pharmacist emails to practitioners caring for patients who recently received opioids and benzodiazepines.
Researchers explored whether...
10/05/2022
Pharmacy Learning Network
News
FDA Approves New Treatment for Amyotrophic Lateral Sclerosis
09/30/2022
Maria Asimopoulos
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee initially recommended against approving sodium phenylbutyrate/taurursodiol in March but changed their decision after reviewing new data.
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee initially recommended against approving sodium phenylbutyrate/taurursodiol in March but changed their decision after reviewing new data.
The FDA’s Peripheral and Central...
09/30/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use